Attila Bérces, PhD
Chief Executive Officer and Founder, Managing Director
Attila received his PhD in computational chemistry at the University of Calgary. Prior to founding Omixon, he worked as Associate Director and Head of Computational Chemistry at AstraZeneca, in Sweden. He received a corporate level IT award for innovative computational chemistry algorithm development at Novartis, where he was Head of Laboratory for Computational Chemistry. Before joining the pharmaceutical industry, he worked as a staff scientist at the Steacie Institute for Molecular Sciences. Dr. Bérces has published 50 peer-reviewed scientific research publications and presented over 30 papers at international conferences. In addition to science, Dr. Bérces studied R&D management and entrepreneurship at Chalmers University in Sweden, where he has been external advisor to seven MSc. students in the field of technology entrepreneurship. Attila's LinkedIn profile
Zoltán Simon, MSc
Chief Operation Office, Managing Director
Zoltán received an MSc in Technical Informatics, an MSc in Banking Informatics from the Budapest University of Technology, and an MSc in Economics from the Corvinus University of Budapest. He has accumulated management expertise at Lufthansa Systems in various positions and at BI Consulting as Consulting Unit leader. Zoltán has worked in Germany and in Hungary. Zoltan's Linkedin Profile
VP Product Innovation
Greg earned his Bachelor of Science in Biology and Biochemistry from University Savoie-Mont Blanc and also holds a M.Sc. in Molecular Biology and Genetic Engineering in addition to a Post Graduate Degree in Business Administration from the University of Grenoble. He brings more than 20 years of technical experience, having worked most recently as the Sr. European Manager for ThermoFisher, responsible for the entire One Lambda portfolio (Transplant Diagnostics) in Europe, prior to this, he was leading the European operations for Linkage Biosciences and successfully introduced LinkSēq™. Gregory also spent 15 years in the Life Sciences, holding managing positions for various reagents and instruments suppliers for the pharmaceutical industry, ranging from Cell Based Assays to Mass Spectrometry. In his private life, Greg loves to practice sports with his family (long distance swimming, running, Nordic skiing, sailing) and also be involved in various social projects, e.g. co-founding “Salto Mag”, a free magazine distributed in France in 60,000 copies dedicated to kid sports.
Greg’s LinkedIn profile
VP Transplant Monitoring
Elmar Schilling, PhD
Chief Technology Officer
He has more than 9 years of professional experience mostly gaining at Eurofins Genomics. He joined Eurofins in 2010 as a project manager for NGS services and served in different roles with growing responsibilities. Most recently he was heading the NGS Manual Innovation Department of Eurofins Genomics at its DNA Campus close to Munich. During his career he gained very high understanding of the entire NGS process within an entrepreneurial setup. He is experienced in leading laboratory experts dedicated to routine analysis or method development and validation.
Elmar's LinkedIn profile
Chief Financial Officer